A general purpose HyperTransport-based Application Accelerator Framework

HyperTransport provides a flexible, low latency and high bandwidth interconnection between processors and also between processors and peripheral omponents. Therefore, the interconnection is no longer a performance bottleneck when integrating application specific accelerators in modern computing systems. Current FPGAs providing huge computational power and permit the acceleration of compute-intensive kernels. We therefore present a general purpose architecture based on HyperTransport and modern FPGAs to accelerate time-consuming computations. Further, we present a prototypical implementation of our architecture. Here we used an AMD Opteron-based system with the HTX Board [6] to demonstrate that common applications can benefit from available hardware accelerators. A cryptographic example showed that the encryption of files, larger then 50 kByte, can be successfully accelerated

Химические элементы в воде объектов водопользования бывшего Семипалатинского испытательного полигона как фактор экологического воздействия

Изучен элементный состав вод объектов водопользования расположенных на территории бывшего Семипалатинского испытательного полигона. Содержание U, Mo и Sr в изученных водах имеют превышения над средним составом подземных вод зон гипергенеза и континентального засоления. Выделены химические показатели и элементы превышающие ПДК это минерализация, общая жесткость, сульфаты, натрий и уран.The elemental composition of the water of odjects of water use in the territory of the former Semey test site was studied. The content of U, Mo and Sr in the studied waters has an excess over the average composition of groundwater in the areas of hypergenesis and continental salinization. Chemical indices and elements above MPC are identified as mineralization, total hardness, sulfates, sodium and uranium

Phase diagram of localization in a magnetic field

The phase diagram of localization is numerically calculated for a three-dimensional disordered system in the presence of a magnetic field using the Peierls substitution. The mobility edge trajectory shifts in the energy-disorder space when increasing the field. In the band center, localized states near the phase boundary become delocalized. The obtained field dependence of the critical disorder is in agreement with a power law behavior expected from scaling theory. Close to the tail of the band the magnetic field causes localization of extended states.Comment: 4 pages, RevTeX, 3 PS-figures (4 extra references are included, minor additions), to appear in Phys. Rev. B as a Brief Repor

Robot-Assisted versus Laparoscopic Donor Nephrectomy: A Comparison of 250 Cases

Living kidney donation is the best treatment for end-stage renal disease, however, the best surgical approach for minimally-invasive donor nephrectomy (DN) is still a matter of debate. This bi-centric study aimed to retrospectively compare perioperative outcomes and postoperative kidney function after 257 transperitoneal DNs including 52 robot-assisted (RDN) and 205 laparoscopic DNs (LDN). As primary outcomes, the intraoperative (operating time, warm ischemia time (WIT), major complications) and postoperative (length of stay, complications) results were compared. As secondary outcomes, postoperative kidney and graft function were analyzed including delayed graft function (DGF) rates, and the impact of the surgical approach was assessed. Overall, the type of minimally-invasive donor nephrectomy (RDN vs. LDN) did not affect primary outcomes, especially not operating time and WIT; and major complication and DGF rates were low in both groups. A history of smoking and preoperative kidney function, but not the surgical approach, were predictive for postoperative serum creatinine of the donor and recipient. To conclude, RDN and LDN have equivalent perioperative results in experienced centers. For this reason, not the surgical approach, but rather the graft- (preoperative kidney function) and patient-specific (history of smoking) aspects impacted postoperative kidney function

Protocol for a Randomized Phase II Trial for Mesh Optimization by Autologous Plasma Coating in Prolapse Repair: IDEAL Stage 3

Introduction: Mesh-related complications especially after vaginal implantation have raised awareness lately because of severe adverse reactions and legal aspects. About 20% of patients suffer from complications after mesh insertion in the anterior vaginal wall. Autologous plasma coating of meshes prior to implantation has shown potential to improve the biocompatibility of meshes in vivo and in vitro. This innovative approach has been developed according to the IDEAL recommendations for surgical innovations. The method has still to be assessed at stage 3 accordingly. Methods: A protocol is developed for a prospective single-blinded randomized controlled phase II trial for biocompatibility optimization of anterior vaginal meshes for prolapse repair by autologous plasma coating versus non-coated meshes. Results: The protocol aims at fulfilling the requirements for stage 3 (assessment) according to IDEAL. Eligible for inclusion are women with primary cystocele, requiring a surgical procedure, suitable for randomization, and willing to be randomized. Participants will be followed up by postal questionnaires (6 months post surgery and 12 months post randomization) and will also be reviewed in clinic 12 and 24 months post surgery. Primary endpoint is the assessment of mesh-related complications following the Clavien–Dindo classifications. QoL, sexual function assessment, efficacy, and validation of an already developed long-term register are considered secondary endpoints. To afford a calculated 10% reduction of postoperative complications through plasma-coated meshes vs. non-coated meshes at 1-year follow-up, a total 214 women in each arm will be necessary to achieve 80% power at a significance level of 5%. Conclusion: The protocol for this randomized clinical trial represents the conditions to assess the surgical innovation of plasma coating of meshes in order to improve the meshes’ biocompatibility at stage 3 according to the IDEAL recommendations. © 2017 Springer Healthcar